Arca Biopharma | ABIO - Current Liabilities


Arca Biopharma reported $15.37M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
Amgen USD 24.96B 534M Mar/2026
Arca Biopharma USD 15.37M 5.59M Dec/2025
Biogen USD 3B 350.5M Mar/2026
Brainstorm Cell Therapeutics USD 11.01M 1.98M Dec/2025
Bristol-Myers Squibb USD 19.16B 4.26B Mar/2026
Capricor Therapeutics USD 35.84M 7.69M Dec/2025
Cipla INR 62.97B 8.13B Sep/2025
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.57M 2.29M Dec/2025
CSL USD 4.61B 207M Dec/2025
Cytokinetics USD 199.18M 3.27M Mar/2026
Daiichi Sankyo JPY 778.55B 77.51B Dec/2025
Gilead Sciences USD 11.81B 485M Dec/2025
GlaxoSmithKline GBP 22.43B 1.04B Mar/2026
Grifols EUR 2.37B 156.97M Dec/2025
Laboratory Of America USD 2.64B 182.5M Mar/2026
Myriad Genetics USD 133.8M 14.2M Dec/2025
Otsuka Holdings JPY 686.12B 63B Mar/2026
Pfizer USD 34.35B 2.64B Mar/2026
United Therapeutics USD 560.6M 14.3M Dec/2025